IMAX Corp Files 8-K on Officer Changes and Compensation

TL;DR

IMAX 8-K: Director/Officer changes & compensation details filed.

AI Summary

IMAX Corporation filed an 8-K on September 16, 2024, reporting on the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also covers compensatory arrangements for certain officers, with the earliest event reported as September 11, 2024.

Why It Matters

This filing provides insight into the corporate governance and executive compensation structure of IMAX Corporation, which can influence investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

• IMAX Corporation (company) — Registrant
• September 11, 2024 (date) — Date of earliest event reported
• September 16, 2024 (date) — Date of report

FAQ

Filing Documents

• d825184d8k.htm (8-K) — 29KB
• 0001193125-24-219620.txt ( ) — 181KB
• imax-20240911.xsd (EX-101.SCH) — 3KB
• imax-20240911_def.xml (EX-101.DEF) — 13KB
• imax-20240911_lab.xml (EX-101.LAB) — 22KB
• imax-20240911_pre.xml (EX-101.PRE) — 14KB
• d825184d8k_htm.xml (XML) — 6KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 September 11, 2024 Date of report (Date of earliest event reported) IMAX Corporation (Exact Name of Registrant as Specified in Its Charter) Canada 001-35066 98-0140269 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 2525 Speakman Drive 902 Broadway , Floor 20 Mississauga , Ontario , Canada L5K 1B1 New York , New York , USA 10010 ( 905 ) 403-6457 ( 212 ) 821-0142 (Address of principal executive offices, zip code, telephone numbers) N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value IMAX The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter): Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 11, 2024, Elizabeth Gitajn, Senior Vice President, Finance & Controller and principal accounting officer of IMAX Corporation (the "Company"), notified the Company of her intent to resign from her position effective October 31, 2024 to accept another professional opportunity. Ms. Gitajn's departure is amicable and not the result of any disagreement with the Company. Natasha Fernandes, the Company's Chief Financial Officer and Executive Vice President, will assume the role and responsibilities of principal accounting officer on an interim basis effective as of Ms. Gitajn's departure until a replacement is identified. Ms. Fernandes' biographical information is set forth in the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 26, 2024, and such information is incorporated herein by reference. No new compensatory arrangements will be entered into with Ms. Fernandes in connection with her appointment as the Company's interim principal accounting officer. There are no arrangements or understandings between Ms. Fernandes and any other persons pursuant to which she was selected as principal accounting officer. There are no family relationships between Ms. Fernandes and any director or executive officer of the Company, and there are no related party transactions between the Company and Ms. Fernandes that would require disclosure under Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMAX Corporation (Registrant) Date: September 16, 2024 By: /s/ Robert D. Lister Name: Robert D. Lister Title: Chief Legal Officer and Senior Executive Vice President By: /s/ Kenneth I. Weissman Name: Kenneth I. Weissman Title: Deputy General Counsel & Corporate Secretary 3